Moderna doses 1st participant in phase 3 clinical trial of combo flu, COVID vaccine

Moderna doses 1st participant in phase 3 clinical trial of combo flu, COVID vaccine
Moderna doses 1st participant in phase 3 clinical trial of combo flu, COVID vaccine
Евгения Матвеец/Getty Images

(NEW YORK) — Moderna announced Tuesday it has dosed its first participant in a phase III clinical trial of a combination influenza and COVID-19 vaccine.

This phase will evaluate the safety and efficacy of the combo vaccine compared to flu and COVID vaccines that are administered separately in two groups, one involving 4,000 adults aged 65 and older and another involving 4,000 adults between ages 50 and 64.

In earlier Phase I/II clinical trials, data showed that the vaccine candidate achieved antibody levels similar or greater to the licensed standalone influenza vaccine and to Moderna’s COVID vaccine.

In a press release, the biopharmaceutical company said the combination vaccine has “the potential to efficiently reduce the overall burden of acute viral respiratory disease” by giving simultaneous protection against flu and COVID in a single dose.

Moderna said this could benefit the public health by increasing vaccine coverage rates for both viruses due to the convenience and easy administration of getting two shots at once.

The company previously announced that it is aiming for regulatory approval for the combination vaccine in 2025.

Moderna did not immediately reply to ABC News’ request for comment.

“Flu and COVID-19 represent a significant seasonal burden for individuals, providers, healthcare systems and economies,” Moderna CEO Stéphane Bancel said earlier this month in a statement when phase I/II clinical trial data was released. “Combination vaccines offer an important opportunity to improve consumer and provider experience, increase compliance with public health recommendations, and deliver value for healthcare systems.”

Moderna estimated between 50 and 100 million COVID vaccine doses will be administered this fall and that, with time, the COVID market will approach the influenza market in the U.S.

Currently, between 500 million and 600 million flu shot doses are administered around the world with 150 million occurring in the U.S., according to Moderna.

Earlier this month, Moderna also said the rates of adverse reactions were not serious and similar to those experienced by the study participants who received the COVID vaccine by itself.

Moderna is not the only company that has been investigating a flu-COVID combination vaccine.

Pfizer-BioNTech announced in November 2022 that it had begun phase I clinical trials and, a month later, announced it had been given Fast Track designation by the U.S. Food and Drug Administration to help expedite the development and review of new drugs.

Pfizer previously told investors during an earnings call in January 2023 that a successful COVID-flu combination vaccine could help increase the percentage of Americans who receive a COVID vaccine.

Novavax also announced it is currently in the process of phase I/II clinical trials. In May 2023, the company said data showed there was a robust immune response among study participants.

Public health officials encourage anyone 6 months and older to get their annual flu and COVID-19 shots to minimize the risk for severe illness.

 

Copyright © 2023, ABC Audio. All rights reserved.

Facebook, Instagram harm young people’s mental health, lawsuit says

Facebook, Instagram harm young people’s mental health, lawsuit says
Facebook, Instagram harm young people’s mental health, lawsuit says
Karl Tapales/Getty Images

(NEW YORK) — Dozens of states are taking action Tuesday against Meta, formerly known as Facebook, for allegedly harming young people’s mental health.

A federal lawsuit and parallel state lawsuits allege that Meta knowingly designed and deployed harmful features on Instagram and Facebook that purposefully addict children and teens.

The states also allege Meta routinely collects data on children under 13 without informing parents or obtaining parental consent.

“Its motive is profit, and in seeking to maximize its financial gains, Meta has repeatedly misled the public about the substantial dangers of its Social Media Platforms,” the lawsuit said. “It has concealed the ways in which these Platforms exploit and manipulate its most vulnerable consumers: teenagers and children. And it has ignored the sweeping damage these Platforms have caused to the mental and physical health of our nation’s youth. In doing so, Meta engaged in, and continues to engage in, deceptive and unlawful conduct in violation of state and federal law.”

This is a developing story. Please check back for updates.

 

Copyright © 2023, ABC Audio. All rights reserved.

Doctors’ group warns sleep and sound machines may be too loud for kids

Doctors’ group warns sleep and sound machines may be too loud for kids
Doctors’ group warns sleep and sound machines may be too loud for kids
Catherine Delahaye/Getty Images

(NEW YORK) — The American Academy of Pediatrics is warning parents and caregivers that excessive exposure to loud noises can be detrimental to children, and sound machines can cause more harm to children than previously thought.

In a statement released Saturday, the AAP said: “What families may not realize is that children are exposed to potentially harmful noise from infancy and that the effects are cumulative over a lifetime.”

ABC News medical correspondent Dr. Darien Sutton told “Good Morning America” that millions of children are at risk of some form of hearing loss.

“One of the reasons why is because children have smaller ear canals. That exposes them to intensification of that higher frequency sound and [makes] them at risk for damage,” Sutton explained.

According to one study published in BMJ Global Health in 2022, more than 1 billion young people are at risk of hearing loss around the world due to unsafe high listening volumes. The AAP cited another study that estimated 60% of adolescents listened to music and audio that was greater than the maximum recommended daily noise intake of 85 decibels averaged over eight hours, a standard that is also for adults and not children.

“The average volume that kids listen to music at is 70 to 100 [decibels],” Sutton said. “That’s the upper limit of normal or the range for most of our headphone outputs.”

“Now, noise above 70 [decibels] for prolonged periods of time can cause damage. Noise at 100, which is the maximum, can cause damage in minutes. And noise over 120 can cause immediate harm,” Sutton continued. “So it’s important to pay attention to those volume settings [and] keep them at least 60 to 70% total.”

With sound machines, often used to lull infants and children to sleep, the AAP warns that they are often too loud for healthy listening.

“The AAP recommends that parents and caregivers consider that if an environment sounds too loud for an adult, it probably is too loud for a child. ‘Too loud’ can mean having to raise your voice to speak with someone just an arm’s length away,” the pediatricians’ group said.

“The Academy of Pediatrics recommends, for example, that nurseries have a volume maximum of around 50 decibels,” Sutton said. “That’s a volume that you and I can speak at without raising our voice. Most of these machines go above that. So if you’re going to use them, turn that volume down, place it away from the bed at least seven feet and make sure that you give limits.”

Sutton recommended parents pay attention to their child’s communication.

“It’s about paying attention to that communication. If you’re finding that your child is speaking loudly, having difficulties with pronunciation, if you’re finding that they’re not reacting to loud noises — these are all some of the reasons why you should get them checked, their hearing checked, because it can help with their learning comprehension and, of course, reduce their risk long-term,” Sutton said.

 

Copyright © 2023, ABC Audio. All rights reserved.

Women who followed DASH diet in midlife reported fewer memory problems in older age, study finds

Women who followed DASH diet in midlife reported fewer memory problems in older age, study finds
Women who followed DASH diet in midlife reported fewer memory problems in older age, study finds
Eleganza/Getty Images

(NEW YORK) — A new study released on Friday found that women who followed a heart-healthy diet reduced their risk of cognitive issues later in life.

Doctors have long touted the Dietary Approaches to Stop Hypertension (DASH) diet, which was designed to lower blood pressure, and now a New York University Women’s Health Study of 5,116 women over 30 years showed that following DASH could reduce risks of self-reported cognitive problems such as memory loss.

Subjective cognitive complaints were based on self-perceived memory loss and follow-ups were conducted via questionnaire.

High blood pressure, especially in midlife, has been shown to be a risk factor for dementia and women make up more than two-thirds of those diagnosed with the disease.

The data showed that women who continued the DASH diet in midlife were about 17% less likely to report memory loss and other cognitive decline decades later.

Dr. Genevieve Jing, a resident in the ABC News medical unit, noted that the subject cognitive complaints were all self-reported without clinical assessment.

The diet consists of higher levels of plant-based foods and lower saturated fat, cholesterol, sodium, and sugar.

Dr. Jing also noted that there is some selection bias due to death, non-response, and loss to follow-up.

The study’s largest takeaway suggests that it’s important to start a healthy diet in midlife to help avoid cognitive decline or impairment later in life.

Copyright © 2023, ABC Audio. All rights reserved.

CVS removing decongestant from shelves after FDA panel says it’s ineffective

CVS removing decongestant from shelves after FDA panel says it’s ineffective
CVS removing decongestant from shelves after FDA panel says it’s ineffective
Jeff Greenberg/Education Images/Universal Images Group via Getty Images

(NEW YORK) — CVS Health is planning to remove one type of a common decongestant from shelves after an advisory committee to the U.S. Food and Drug Administration said it was ineffective earlier this year.

The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications.

Although PE has been used as a decongestant for nearly a century, experts have been questioning its efficacy for years.

The FDA Nonprescription Drugs Advisory Committee unanimously voted in September that PE did not improve nasal congestion any more than a placebo at the dosage given for OTC use.

In response, CVS said it is removing products, in which PE is the only active ingredient, from store shelves. This means products like Dayquil, which uses a combination of active ingredients, will remain available for purchase.

“We are aware of the FDA Advisory Committee’s position on oral phenylephrine (PE) and will follow direction from the FDA to ensure products we sell comply with all laws and regulations,” CVS Health said in a statement. “We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores. Other oral cough and cold products will continue to be offered to meet consumer needs.”

CVS did not give specifies on brands that will be removed.

The FDA told ABC News it has not yet determined whether it no longer considers PE to be a safe and effective medication and has not ordered the product to be removed from shelves. CVS’s move is voluntary.

“The FDA has no further information to provide at this time regarding the timing of any decision the agency may make following the advisory committee meeting,” the federal health agency said.

The Consumer Healthcare Products Association told ABC News that the advisory committee’s recommendation is a non-binding decision and not a change in regulation.

“FDA is currently in the process of reviewing the regulatory status of oral phenylephrine (PE) following September’s advisory committee meeting,” CHPA said in a statement. “Until FDA makes a determination on the committee’s recommendation, oral PE remains a Category 1 OTC ingredient, which is generally recognized as safe and effective.”

Concerns were first raised about PE in 2007. Since then, evidence has accumulated showing that the drug offers little to no relief for nasal congestion.

Experts believe this is because the body processes the drug before it reaches the nasal passages where it needs to work.

It’s unclear if other major retail pharmacy chains will follow in CVS’s footsteps.

Walgreens Boots Alliance would not disclose whether it is planning to remove products with PE from store shelves and said it would defer to the FDA.

“Walgreens follows FDA regulations. We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps,” a Walgreens spokesperson told ABC News.

Other major pharmacy chains including Albertsons, Costco and Kroger did immediately reply to ABC News’ request for comment. Walmart did not have an answer immediately available.

ABC News’ Sasha Pezenik and Sony Salzman contributed to this report.

Copyright © 2023, ABC Audio. All rights reserved.

FDA considers ban on some Black women’s hair products that have caused years of harm

FDA considers ban on some Black women’s hair products that have caused years of harm
FDA considers ban on some Black women’s hair products that have caused years of harm
wsfurlan/Getty Images

(NEW YORK) — Recently, the U.S. Food and Drug Administration (FDA) said it was considering issuing a proposed rule to ban hair straighteners with formaldehyde.

Formaldehyde is a chemical and a known carcinogen which has been found to cause an increased risk of endometrial cancers when used in chemical hair straighteners, often marketed to Black women.

However, it’s not just straighteners. A plethora of products — including perms, hair relaxers, lotions and gels — geared towards Black women have been found to raise the risk of diabetes, obesity, cardiovascular disease and health risks while pregnant. Experts say this has been occurring for years.

In Western culture, straight and long hair has been considered a traditional beauty standard while textured hair with tight curls or coils has not.

“There’s a whole history of hair and hair care in the Black community, and some of it stems from issues of racism and discrimination against how women wear their hair and what’s considered a professional hairstyle in office settings, for example, or in school,” Dr. Kimberly Bertrand, an associate professor of medicine at Boston University Chobanian & Avedisian School of Medicine, told ABC News.

“So, there’s lots of reasons women may have used chemical hair relaxers, historically and even currently, everything stemming from the social pressures to have their hair look a certain way smooth and sleek,” she continued. “Some women find that their hair is just easier to manage when it’s relaxed and then of course there’s individual style and fads and trends, and how people want to wear their hair.”

Studies have shown that many of these products contain chemicals, such as phthalates, which are known to be endocrine disruptors, meaning they mimic, block or interfere with hormones in the body.

According to one Harvard professor, 50% of hair products advertised to Black women contain this group of chemicals while only about 7% of products advertised to white women do the same.

While exposure to phthalates has been linked to obesity, diabetes and pre-term birth, they’ve also been linked to uterine fibroids and uterine cancer.

“Some of the things that we’ve seen with permanent relaxers is the association with several different types of cancer, including breast and uterine cancer and ovarian cancer,” Dr. Jasmine McDonald, an assistant professor in the department of epidemiology at Columbia University’s Mailman School of Public Health, told ABC News.

“We’ve also seen associations with the chemicals that are present within these products associated with uterine fibroids and fertility, so a lot of hormonal driven conditions, and that’s mainly because a lot of the chemicals of concern are endocrine-disrupting chemicals,” she said.

McDonald performed a study looking at the use of these products in early childhood and its association and found it was associated with an earlier starting age for one’s period, which increases the risk for breast cancer.

Meanwhile, Bertrand is an investigator on the long-running Black Women’s Health Study, which found that Black post-menopausal women who used chemical hair relaxers for more than five years or more than five times a year had a nearly 50% increased risk of developing uterine cancer compared to Black women who never or infrequently used these relaxers.

McDonald said some of the damage can be undone if users switch their products. For example, phthalates are chemicals that are excreted very quickly so small changes can make a difference.

“The great thing about it is there’s been intervention studies that have shown that if you remove that product, and you replace it with a cleaner product, you will see a decrease in your exposures of these chemicals of concern that have been associated with these chronic conditions,” she said.

Both experts say if the FDA does decide to ban formaldehyde it would be an important first step, but that it should extend to more chemicals.

However, the agency is still very early in the regulatory process and its notice only suggests it may a consider a proposal in the future.

“The fact of the matter is it’s one chemical, and we’re exposed to a plethora of chemicals, not just formaldehyde,” said McDonald. “So, I think it’s a very important ban. But it’s just one step that isn’t exhaustive to all the other chemicals of concern.”

Copyright © 2023, ABC Audio. All rights reserved.

New study finds potential link between eating red meat and developing Type 2 diabetes

New study finds potential link between eating red meat and developing Type 2 diabetes
New study finds potential link between eating red meat and developing Type 2 diabetes
Grace Cary/Getty Images

(NEW YORK) — A new study has found a link between eating red meat, especially processed red meat, and an increased risk of developing Type 2 diabetes.

ABC News chief medical correspondent Dr. Jennifer Ashton explained the findings of the study, which was led by researchers at Harvard T.H. Chan School of Public Health and published Thursday in The American Journal of Clinical Nutrition.

“We’re talking about lamb, beef, pork, sausage, hot dogs, burgers,” said Ashton. “This was a big study, over 200,000 people followed for 30 years, [that] basically found a direct link and association — didn’t show cause and effect, but the more red meat consumed the higher risk of developing Type 2 diabetes over that period of time.”

Researchers tracked the eating patterns of 216,695 adults over decades and noted whether they developed various health problems, assessing their diet with food frequency questionnaires every two to four years, for up to 36 years. During that time, more than 22,000 participants developed Type 2 diabetes.

The research showed that the more servings of red meat a person ate, the higher was their likelihood of developing Type 2 diabetes. The study did not conclude that eating red meat causes a person to develop Type 2 diabetes, only that there appeared to be an association.

U.S. dietary guidelines recommend that if you are getting protein from meat, you should choose lean meats, like chicken breast, over processed meats.

Researchers also noted that people can prevent or offset their potential risk of developing Type 2 diabetes by “substituting one daily serving of red meat for another protein source.” They further discovered that “substituting a serving of nuts and legumes was associated with a 30% lower risk of Type 2 diabetes, and substituting a serving of dairy products was associated with a 22% lower risk,” according to the study.

“That was the silver lining,” Ashton said. “They did find consuming as little as half a serving a day of legumes and nuts dramatically lowered that risk.”

Ashton also emphasized the importance of knowing your own risks, and assessing the factors that can contribute to developing Type 2 diabetes, such as genetics, exercise, weight and diet.

“If you have a family history or have had diabetes in pregnancy, you are at higher risk. Getting screened with a simple blood test, everyone should do that regardless of their weight,” Ashton encouraged. “But keeping your weight in a healthy range is key for preventing or lowering the risk of Type 2 diabetes.”

Echoing the study findings, Ashton further said “swapping out proteins” can be beneficial, and that while “we all love our occasional burger,” foods like “fish, plant based protein [are] definitely healthier.”

Finally, Ashton reminded that exercise is key to good health.

“Every little bit counts, including walking, so getting those steps in,” she said.

The Office of Disease Prevention and Health Promotion recommends that adults get at least 150 minutes of moderate aerobic activity every week, or about 22 minutes a day.

Dr. Liz Ghandakly, from the ABC News medical unit, noted that the study participants were all health professionals, 81% of whom were female and about 90% of whom were white, which she said may limit how broadly the data can be generalized.

The study also relied on participants self-reporting their average frequency of eating certain foods over the past 12 months when they filled out the questionnaire, which could have affected accuracy.

Copyright © 2023, ABC Audio. All rights reserved.

People with HIV at higher risk of COVID reinfection: CDC

People with HIV at higher risk of COVID reinfection: CDC
People with HIV at higher risk of COVID reinfection: CDC
Jason Armond/Los Angeles Times via Getty Images

(NEW YORK) — People with HIV are at increased risk of being reinfected with the virus that causes COVID-19, according to new federal data.

Researchers from the Centers for Disease Control and Prevention and the Chicago Department of Public Health followed adult residents in Chicago from their first reported infection from March 2020 through the end of May 2022, according to the report published Wednesday by the CDC.

The team compared COVID test laboratory data and COVID vaccine administration data to Chicago’s Enhanced HIV/AIDS Reporting System.

About 5% experienced reinfection among more than 453,000 Chicago residents who tested positive for the virus.

Rates of reinfection were higher among people with HIV (6.7%) than among people without HIV (5.2%).

People with HIV are more likely to have completed a primary COVID vaccine series plus a booster before their reinfection — 31.8% versus 27% for those without HIV.

Reinfection rates were consistently higher throughout the pandemic for people with HIV and were highest during the original omicron variant phase, according to the report.

“Understanding if persons with HIV have a higher risk for SARS-CoV-2 reinfection may help tailor future COVID-19 public health guidance,” the authors wrote. “[Persons with HIV] should follow the recommended COVID-19 vaccine schedule, including booster doses, to avoid SARS-CoV-2 reinfections.”

Those who were reinfected were more likely to be male, older and Black or African American compared to those without HIV, the study found.

People with HIV were also less likely to have been unvaccinated at the time of their first infection compared to people without HIV.

The report notes the findings are a reminder about the risks of reinfection for those who are immunocompromised.

HIV can weaken the immune system, infecting and destroying CD4 cells, which causes the white blood cell count to drop and compromises the immune system.

This means that people with HIV are susceptible to COVID infection especially those who are not on antiretroviral therapy (ART).

ART is a combination of drugs that suppresses a person’s viral load until HIV Is virtually undetectable. The ability of ART to control viral replication has been shown to greatly improve immune system function, studies show.

“Evaluating the association between HIV infection and SARS-CoV-2 reinfections using surveillance data can help strengthen public health recommendations including the need for extra doses as part of a primary series, booster doses of vaccine, and optimized ART in [persons with HIV],” the authors wrote. “Tailored guidance and prevention messaging for [persons with HIV] can help reduce the elevated risk we identified in this analysis and limit continued SARS-CoV-2 transmission.”

Copyright © 2023, ABC Audio. All rights reserved.

Pregnant women, new mothers are at risk amid Israel-Hamas conflict: Experts

Pregnant women, new mothers are at risk amid Israel-Hamas conflict: Experts
Pregnant women, new mothers are at risk amid Israel-Hamas conflict: Experts
pawel.gaul/Getty Images

(NEW YORK) — As the Israel-Hamas conflict continues — with food, water and fuel running out in Gaza — pregnant people and those who have just given birth are facing a crisis, experts and humanitarian organizations said.

About 50,000 people are estimated to be pregnant in Gaza with about 160 estimated to give birth every day, according to the United Nations Population Fund (UNFPA).

Additionally, an estimated 73,000 are pregnant in the West Bank, with more than 8,000 expected to give birth within the next month, the UNFPA said.

Experts said pregnant women and new mothers are facing life-threatening challenges to accessing safe care, putting their health and the health of their babies at risk.

“I think we have to start off with the basic premise, which is that war is bad for health,” Dr. Dabney P. Evans, an associate professor of global health in the Rollins School of Public Health at Emory University, told ABC News. “There’s no good health outcome that is going to come as a result of war and conflict.”

“And then from a public health perspective, we would tend to focus on vulnerable groups and so pregnant women and children … would be among the populations that we would want to pay special attention, to ensure that their health needs are being met,” she said.

Blocked access to care

One of the biggest problems facing pregnant and post-partum people right now is a lack of access to care.

An editorial in The BMJ on the risks pregnant women face in war discussed how there’s no transportation to get someone to a medical center or to a health care provider.

“You have to be able to provide some sort of prenatal care and, generally, that’s gonna be difficult to get them to a clinic unless they have some sort of transportation, depending on the type of zone that you’re in,” Dr. Harry Johnson, an OB/GYN at the University of Maryland Medical Center, who has experience practicing in war zones, told ABC News.

“If you’re house bound, because of the things that are going on around you, you’re not able to get to a health care facility, you don’t have access into to prenatal care, and you don’t have access to the hospital where you deliver the babies,” he continued. “So, you’re pretty much are limited to home care, which is not always adequate.”

This puts pregnant people at risk of having an infant with low birthweight or suffering a premature birth, stillbirth or even miscarriage, experts said.

He added that hospitals also have nurseries to care for newborns so, if someone gives birth at home, there’s no access to health care providers who can keep an eye on the infants’ health.

Even if a patient is able to get to a hospital, the medical center might be overwhelmed due to caring of those who have been injured, have underlying conditions or are even sheltering at the hospital due to losing their homes, experts said.

“There’s more attention, more resources being pooled into acute traumatic events, of injuries that are inflicted by war and in conflict,” Dr. Mimi Niles, an assistant professor at New York University Rory Meyers College of Nursing and a practicing midwife, told ABC News.

She added, “What does that do to the people who are seeking out health care for other reasons? Their lives do not stop when conflict [starts]. People don’t stop being pregnant, right? Or people don’t stop being in labor.”

Risk to safety

Another risk for pregnant people and new mothers’ is their immediate safety due to air strikes and raids.

With a potential ground offensive looming, Israel told more than one million people in northern Gaza last week to flee south to escape the fighting.

The UNFPA shared the testimony of a 30-year-old pregnant woman who been forced to evacuate her home four times, each time with only a small bag of clothes, who said “each time feels like a race against death.”

Pregnant women or those who just gave birth may not be able to move to safety depending on their condition.

“For anyone that has been pregnant, they will know that their doctor would suggest not flying or not traveling far from their local home base as their delivery draws nearer, and for people that are in conflict situations or humanitarian situations, they may not have the ability to control that,” Evans, the director of Emory’s Center for Humanitarian Emergencies, said.

Hospitals may also be at risk of attacks. Israel’s evacuation orders included 22 hospitals treating more than 2,000 patients in northern Gaza.

Experts told ABC News that health care facilities in any conflict zone should be neutral players.

“We’re medical providers, so we can’t really say what’s going on outside the hospital, but we would encourage that, and we would hope that, hospitals are protected and that they’re really safe zones,” Johnson said. “I think medical personnel are really neutral players in conflict zones and what we focus on really is taking care of patients — and in my particular case, would be pregnant women and newborns — and it’s just important that we respect that neutrality.”

Disputed family planning services

While the blockades may be preventing pregnant people and new mothers from accessing care, it’s also affecting access to family planning services.

This means people trapped in conflict zones may not be able to reach their health care providers to receive reproductive health care or have access to contraceptive, taking reproductive choices away from civilians.

“There are people who maybe were scheduled to get routine care or routine contraceptive care and routine abortion care, and they no longer have access to that care, because that clinic is closed or it’s been destroyed or there might be blockades,” said Niles. “These are all things that are part of what we call the reproductive justice framework, making sure that people have access to all the options that help them realize their own full humanity.”

Copyright © 2023, ABC Audio. All rights reserved.

Could low serotonin levels contribute to Long COVID?

Could low serotonin levels contribute to Long COVID?
Could low serotonin levels contribute to Long COVID?
Jackyenjoyphotography/Getty Images

(NEW YORK) — Decreased levels of serotonin in the body may be a contributing factor in the development and persistence of so-called ‘long COVID’ symptoms, according to a new study.

Researchers suggest that, even after acute COVID symptoms subside, traces of the virus remain in the gastrointestinal tract, which is where the majority of circulating serotonin is produced, and where the virus reduces levels of the essential chemical. The low levels of serotonin might in turn lead to some of the more commonly reported long COVID symptoms, such as cognitive difficulties and memory problems, according to the study.

For the study, published Monday in the journal Cell, researchers at Penn Medicine conducted an analysis using questionnaire surveys and medical chart reviews of 1,540 patients hospitalized with long COVID.

Patients reported symptoms including fatigue, cognitive difficulties, headaches, anxiety, loss of endurance, problems with sleep and memory loss — all typically associated with long COVID diagnosis.

The study also analyzed blood samples taken from 58 long COVID patients and compared them to samples taken from 30 people who were fully recovered from COVID, as well as to samples taken from 60 people in the midst of an active COVID infection.

“These findings provide a possible explanation for neurocognitive symptoms associated with viral persistence in Long COVID, which may extend to other post-viral syndromes,” the authors wrote.

Researchers found that long COVID patients had different levels of chemicals in their body compared to those who had recovered, the most significant of which were levels of serotonin.

Serotonin is a neurotransmitter, sometimes referred to as the “feel good” chemical, that carries messages between nerve cells in the brain and throughout the body, helping to regulate mood. But serotonin also plays a significant role in digestion, sleep, bone health, wound healing, blood clotting and sexual desire, according to the Cleveland Clinic.

The researchers believe leftover bits of the virus in the gastrointestinal tract cause the body to produce proteins that lead to inflammation and an inability to absorb tryptophan, an amino acid that’s essential for the production and maintenance of neurotransmitters, including serotonin. The resulting low levels of serotonin lead to memory problems and other cognitive issues.

Serotonin levels also were predictive of whether a patient in the study fully recovered or developed long-term complications after COVID infection. Serotonin levels remained reduced in severe cases of long COVID. Long COVID patients also had higher levels of enzymes in the body that can break down serotonin, which in turn may also reduce levels of the neurotransmitter.

Researchers say further studies are needed to confirm a causal link between low serotonin levels and long COVID, with further, multiple steps needed before the research can result in a treatment.

Long COVID is a condition that occurs when patients still exhibit symptoms at least four weeks after they have cleared the infection. In some cases, long COVID symptoms can be experienced for months or years.

Though symptoms often vary, they can include fatigue, difficulty breathing, headaches, brain fog, joint and muscle pain, and continued loss of taste and smell, according to the Centers for Disease Control and Prevention.

Despite the new findings about serotonin’s possible role, it’s unclear what causes people to develop long COVID, and research is ongoing.

Earlier this year, the Biden administration announced it was forming a new Office of Long COVID Research and Practice to study the condition and help those who have been diagnosed with it.

The office, which will be under the Department of Health and Human Services, “is charged with on-going coordination of the whole-of-government response to the longer-term effects of COVID-19,” according to an HHS news release.

Copyright © 2023, ABC Audio. All rights reserved.